Bio-Path Holdings Inc.

(BPTH) Trade

By |

Profile

Bio-Path Holdings Inc is a US-based clinical and preclinical stage company. It focuses on oncology antisense drug development utilizing a novel technology. The company's drug delivery and antisense technology referred as DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by enzymes when circulating in vivo, incorporated inside of a neutrally charged lipid bilayer. The lead drug candidate of the company is prexigebersen which is a nonproprietary drug for acute myeloid leukemia as well as solid tumors, including breast cancer and ovarian cancer. Its other drug candidate is Liposomal Bcl2 which targets the protein Bcl2, which is responsible for driving cell proliferation of all cancers.

Contact Information

Website: www.biopathholdings.com
Email: dmorris@biopathholdings.com
Main Phone: +1 832 742-1357
Address: 4710 Bellaire Boulevard
Address 2: Suite 210
State: TX
City / Town: Bellaire
Country: USA
Postal Code: 77401

Issuer Information

Exchange: NSC
CEO: Peter H. Nielsen
Employees: 9
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.26 $ 0.0018 (0.70%)
Last Price 0.26 Change $ 0.0018 Change % 0.70 Tick N/A
Bid N/A Bid Size 0.00 Ask 0.30 Ask Size 2,000.00
Open 0.27 High 0.29 Low 0.25 Prev Close 0.26
Last Trade Volume 55,063 52 Wk Hi 3.09 52 Wk Low 0.21
Market Cap 3.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 13,602,294.00 EPS (TTM) -0.79 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 7
Number of Buys 5 7
Number of Sells 0 0
Net Activity 207500 257500
Last 10 Buys Shares
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 20 20 20 20
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/13/17 11/13/17 11/13/17 11/13/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1